Items per page
Sort by

Send to:

Choose Destination

Search results

Items: 1 to 20 of 68


Gene mutations of platelet glycoproteins and response to tirofiban in acute coronary syndrome.

Mansur AP, Roggerio A, Takada JY, Caribé PM, Avakian SD, Strunz CM.

Sao Paulo Med J. 2016 Jan 19. pii: S1516-31802016005001103. [Epub ahead of print]


Unveiling specific triggers and precipitating factors for fatal cardiac events in inherited arrhythmia syndromes.

Nakajima T, Kaneko Y, Kurabayashi M.

Circ J. 2015;79(6):1185-92. doi: 10.1253/circj.CJ-15-0322. Epub 2015 Apr 30. Review.


Rs6922269 marker at the MTHFD1L gene predict cardiovascular mortality in males after acute coronary syndrome.

Hubacek JA, Staněk V, Gebauerová M, Poledne R, Aschermann M, Skalická H, Matoušková J, Kruger A, Pěnička M, Hrabáková H, Veselka J, Hájek P, Lánská V, Adámková V, Pitˇha J.

Mol Biol Rep. 2015 Aug;42(8):1289-93. doi: 10.1007/s11033-015-3870-1. Epub 2015 Mar 26.


The -844 G>A PAI-1 polymorphism is associated with acute coronary syndrome in Mexican population.

García-González IJ, Valle Y, Sandoval-Pinto E, Valdés-Alvarado E, Valdez-Haro A, Muñoz-Valle JF, Flores-Salinas HE, Figuera-Villanueva LE, Dávalos-Rodríguez NO, Padilla-Gutiérrez JR.

Dis Markers. 2015;2015:460974. doi: 10.1155/2015/460974. Epub 2015 Feb 19.


Impact of gene polymorphisms, platelet reactivity, and the SYNTAX score on 1-year clinical outcomes in patients with non-ST-segment elevation acute coronary syndrome undergoing percutaneous coronary intervention: the GEPRESS study.

Palmerini T, Calabrò P, Piscione F, De Servi S, Cattaneo M, Maffeo D, Toso A, Bartorelli A, Palmieri C, De Carlo M, Capodanno D, Barozzi C, Tomasi L, Della Riva D, Mariani A, Taglieri N, Reggiani LB, Bianchi R, De Rosa R, Mariani M, Podda G, Généreux P, Stone GW, Angiolillo DJ.

JACC Cardiovasc Interv. 2014 Oct;7(10):1117-27. doi: 10.1016/j.jcin.2014.04.020. Epub 2014 Sep 17.


Reply: The importance of genotype variation beyond different antiplatelet therapy in nonresponder patients.

Aradi D, Komócsi A.

J Am Coll Cardiol. 2014 Jul 22;64(3):334. doi: 10.1016/j.jacc.2014.04.037. No abstract available. Erratum in: J Am Coll Cardiol. 2014 Jul 22:64(3):335.


The importance of genotype variation beyond different antiplatelet therapy in nonresponder patients.

Sardella G, Calcagno S.

J Am Coll Cardiol. 2014 Jul 22;64(3):333-4. doi: 10.1016/j.jacc.2014.02.613. No abstract available.


Strategies to reduce bleeding risk in acute coronary syndromes and percutaneous coronary intervention: new and emerging pharmacotherapeutic considerations.

Coons JC, Miller T.

Pharmacotherapy. 2014 Sep;34(9):973-90. doi: 10.1002/phar.1447. Epub 2014 Jun 5. Review.


The SNP rs1883832 in CD40 gene and risk of atherosclerosis in Chinese population: a meta-analysis.

Yun Y, Ma C, Ma X.

PLoS One. 2014 May 14;9(5):e97289. doi: 10.1371/journal.pone.0097289. eCollection 2014.


Cys327Cys polymorphism of the PAPP-A gene (pregnancy associated plasma protein A) is related to mortality of long term hemodialysis patients.

Kalousová M, Jáchymová M, Muravská A, Kuběna AA, Dusilová-Sulková S, Tesař V, Zima T.

Clin Biochem. 2014 May;47(7-8):578-83. doi: 10.1016/j.clinbiochem.2014.03.006. Epub 2014 Mar 22.


Genetic polymorphism rs6922269 in the MTHFD1L gene is associated with survival and baseline active vitamin B12 levels in post-acute coronary syndromes patients.

Palmer BR, Slow S, Ellis KL, Pilbrow AP, Skelton L, Frampton CM, Palmer SC, Troughton RW, Yandle TG, Doughty RN, Whalley GA, Lever M, George PM, Chambers ST, Ellis C, Richards AM, Cameron VA.

PLoS One. 2014 Mar 11;9(3):e89029. doi: 10.1371/journal.pone.0089029. eCollection 2014.


Association of endothelial nitric oxide synthase (eNOS) gene polymorphism (Glu 298 Asp) with coronary artery disease in subjects from Multan, Pakistan.

Taqddus A, Saad AB, Pasha B, Latif M, Safdar S, Shaikh RS, Ali M, Iqbal F.

Pak J Pharm Sci. 2014 Mar;27(2):357-63.


Relation between K469E gene polymorphism of ICAM-1 and recurrence of ACS and cardiovascular mortality.

Liu LZ, Wu EP, Liu HL.

Asian Pac J Trop Med. 2013 Nov;6(11):916-20. doi: 10.1016/S1995-7645(13)60164-9.


Cytochrome CYP2C19 polymorphism and risk of adverse clinical events in clopidogrel-treated patients: a meta-analysis based on 23,035 subjects.

Mao L, Jian C, Changzhi L, Dan H, Suihua H, Wenyi T, Wei W.

Arch Cardiovasc Dis. 2013 Oct;106(10):517-27. doi: 10.1016/j.acvd.2013.06.055. Epub 2013 Sep 27. Review.


Single nucleotide polymorphisms in cholesteryl ester transfer protein gene and recurrent coronary heart disease or mortality in patients with established atherosclerosis.

Virani SS, Lee VV, Brautbar A, Grove ML, Nambi V, Alam M, Elayda M, Wilson JM, Willerson JT, Boerwinkle E, Ballantyne CM.

Am J Cardiol. 2013 Nov 1;112(9):1287-92. doi: 10.1016/j.amjcard.2013.05.073. Epub 2013 Jul 25.


[Relevance of CYP2C19 2 regarding platelet reactivity in patients with acute coronary syndrome treated with clopidogrel].

Cano P, Consuegra-Sánchez L, Conesa P, Torres-Moreno D, Jaulent L, Dau D, Picó F, Villegas M.

Med Clin (Barc). 2014 Jul 7;143(1):6-12. doi: 10.1016/j.medcli.2013.04.042. Epub 2013 Jul 10. Spanish.


[Elevated coronary mortality in Mauritius: risk factors and genetic analyses].

Baligadoo S.

Bull Acad Natl Med. 2012 Oct;196(7):1381-94; discussion 1394-6. French.


Update on Kawasaki disease: epidemiology, aetiology and pathogenesis.

Yim D, Curtis N, Cheung M, Burgner D.

J Paediatr Child Health. 2013 Sep;49(9):704-8. doi: 10.1111/jpc.12172. Epub 2013 Apr 7. Review.


FOXP3 genetic variant and risk of acute coronary syndrome in Chinese Han population.

Yang Q, Chen Y, Yong W.

Cell Biochem Funct. 2013 Oct;31(7):599-602. doi: 10.1002/cbf.2945. Epub 2013 Jan 9.

Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk